Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-30, Stock:NVS, The news for the past five days is as follows:
2018-10-23: NEWS1: How Is Novartis Valued?.NEWS2: Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT.NEWS3: Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT.NEWS4: Biotech Stocks Earnings Lineup for Oct 24: VRTX, ALXN & SRPT.NEWS5: How Novartis’s Alcon Performed in Third Quarter.NEWS6: How Novartis’s Sandoz Performed in the Third Quarter.NEWS7: Why Aduro Biotech Crashed 29.5% Today.NEWS8: Why Aduro Biotech Crashed 29.5% Today.
2018-10-24: NEWS1: Incyte (INCY) to Report Q3 Earnings: What's in the Cards?.NEWS2: Incyte (INCY) to Report Q3 Earnings: What's in the Cards?.NEWS3: A Performance Overview of Johnson & Johnson.NEWS4: Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG.NEWS5: Drug Stocks' Earnings Due on Oct 25: MRK, BMY, GILD & CELG.NEWS6: What Analysts Recommend for Novartis after Q3 Earnings.
2018-10-25: NEWS1: Bulls bet this financial name is set to bounce. Plus, the....NEWS2: How Is Johnson & Johnson’s Vision Care Business Positioned?.
2018-10-26: NEWS1: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS2: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS3: What's in the Cards for Glaxo (GSK) This Earnings Season?.NEWS4: What's in the Cards for Glaxo (GSK) This Earnings Season?.NEWS5: Celgene’s Revlimid and Pomalyst Saw Solid Q3 Growth.NEWS6: Pharma Stock Roundup: MRK, BMY Q3 Earnings, Cancer Data Presentations at ESMO.NEWS7: Gilead (GILD) Beats on Q3 Earnings & Sales, Updates View.NEWS8: Gilead (GILD) Beats on Q3 Earnings & Sales, Updates View.NEWS9: The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default.NEWS10: Novartis Gets EC Approval For Cosentyx Label Update In Europe - Quick Facts.NEWS11: Novartis Gets EC Approval For Cosentyx Label Update In Europe - Quick Facts.
2018-10-29: NEWS1: Health Care Sector Update for 10/29/2018: MLNT,BDSI,TXMD,PFE,NVS.NEWS2: Health Care Sector Update for 10/29/2018: MLNT,BDSI,TXMD,PFE,NVS.NEWS3: Drugmakers tout new medicines as eye disease battle intensifies.NEWS4: Recommendations for GlaxoSmithKline on October 29.NEWS5: Health Care Sector Update for 10/29/2018: BDSI,TXMD,PFE,NVS.NEWS6: Health Care Sector Update for 10/29/2018: BDSI,TXMD,PFE,NVS.NEWS7: Health Care Sector Update for 10/29/2018: RKDA, TXMD, PFE, NVS.NEWS8: Health Care Sector Update for 10/29/2018: RKDA, TXMD, PFE, NVS.NEWS9: Novartis, Pfizer join forces on potentially lucrative fatty liver disease.NEWS10: Biotech Stocks Facing FDA Decision In November.NEWS11: Biotech Stocks Facing FDA Decision In November.NEWS12: Pfizer In Clinical Development Deal With Novartis To Advance Treatment Of NASH.NEWS13: Pfizer In Clinical Development Deal With Novartis To Advance Treatment Of NASH.

Answer: Rise